Eight people are diagnosed with acute myeloid leukaemia in the UK each day, accounting for over 2000 deaths each year. But a new potential therapeutic target has been uncovered, which could help improve future treatments. Scientists from Cardiff University have identified a biological molecule, Gata2, which could provide new avenues for developing effective therapies for… Read More »
Dive Brief: American Well on Tuesday launched a new acute care telehealth cart to connect patients and care teams to remote specialists. The American Well 760 Cart is designed for health systems performing telemedicine via the company’s software or an existing Cisco infrastructure. Features include a touch panel and 20x zoom to increase image clarity,… Read More »
Print this page PRINCETON, N.J.–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE:BMY) today announced the U.S. Food and Drug Administration (FDA) has expanded the indication for Sprycel ® (dasatinib) tablets to include the treatment of pediatric patients one year of age and older with newly diagnosed Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in combination with chemotherapy.1 Sprycel… Read More »
So far in 2018, at least 106 confirmed cases of acute flaccid myelitis (AFM) have occurred in the U.S.1 The mysterious disease, which is reminiscent of polio, primarily affects children and can cause permanent paralysis, continues to baffle the U.S. Centers for Disease Control and Prevention (CDC), which has been investigating the disease since 2014.… Read More »
FDA Approves Daurismo (glasdegib) for Patients with Acute Myeloid Leukemia Print this page November 21, 2018 — The U.S. Food and Drug Administration today approved Daurismo (glasdegib) tablets to be used in combination with low-dose cytarabine (LDAC), a type of chemotherapy, for the treatment of newly-diagnosed acute myeloid leukemia (AML) in adults who are 75… Read More »